Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) was the target of a significant decrease in short interest in June. As of June 30th, there was short interest totaling 24,328 shares, a decrease of 65.5% from the June 15th total of 70,596 shares. Currently, 0.4% of the company’s stock are sold short. Based on an average daily volume of 48,429 shares, the days-to-cover ratio is presently 0.5 days.
Institutional Trading of Oxbridge Re
Large investors have recently added to or reduced their stakes in the business. International Assets Investment Management LLC increased its stake in shares of Oxbridge Re by 61.2% during the 1st quarter. International Assets Investment Management LLC now owns 48,000 shares of the insurance provider’s stock worth $54,000 after purchasing an additional 18,227 shares during the last quarter. J.W. Cole Advisors Inc. lifted its stake in shares of Oxbridge Re by 106.1% in the 4th quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock valued at $90,000 after purchasing an additional 35,000 shares during the last quarter. Henrickson Nauta Wealth Advisors Inc. boosted its holdings in Oxbridge Re by 100.0% in the fourth quarter. Henrickson Nauta Wealth Advisors Inc. now owns 137,400 shares of the insurance provider’s stock worth $185,000 after purchasing an additional 68,700 shares in the last quarter. Finally, Virtu Financial LLC bought a new stake in Oxbridge Re in the third quarter worth $32,000. 5.64% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of research analysts recently commented on OXBR shares. Zacks Research raised shares of Oxbridge Re to a “hold” rating in a research report on Wednesday, June 17th. Weiss Ratings downgraded shares of Oxbridge Re from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday. Finally, Maxim Group decreased their target price on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a research note on Tuesday, June 16th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $3.00.
Oxbridge Re Price Performance
Shares of OXBR remained flat at $1.58 during midday trading on Wednesday. The stock had a trading volume of 55,977 shares, compared to its average volume of 339,134. The firm has a market cap of $12.80 million, a P/E ratio of -6.32 and a beta of 2.01. The company has a debt-to-equity ratio of 0.16, a quick ratio of 8.15 and a current ratio of 8.15. Oxbridge Re has a 52 week low of $0.66 and a 52 week high of $2.86. The business has a 50-day simple moving average of $1.06 and a 200 day simple moving average of $1.04.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Featured Stories
- Five stocks we like better than Oxbridge Re
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
